Gilead Sciences Exec Says Weekly Oral HIV Prevention Drug Expected To Launch In Q1 2027

Benzinga News-desk www.benzinga.com Neutral 91.8%

Neg 0% Neu 91.8% Pos 0%

https://event.webcasts.com/starthere.jsp?ei=1776111&tp_key=7239e5582f&tp_special=8

Comments

No comments yet. Be the first!